Organisation paid for research Program year 2025 Source: CMS Open Payments

Noble Clinical Research, LLC

Neither a doctor nor a teaching hospital

Research payments

$1,231,337

87 payments

Through program year 2025, Noble Clinical Research, LLC is reported as receiving $1,231,337 in research payments, across 87 payments.

By program year

6 rows

Year	Kind	Amount	Payments
2025	Research	$537,986	27
2024	Research	$97,398	2
2023	Research	$169,946	30
2022	Research	$355,016	18
2021	Research	$54,500	1
2019	Research	$16,491	9

Breakdown

Who paid Research payments · program years 2019–2025

Organon LLC $606,984 49 payments
Cleerly, Inc. $442,252 27 payments
American Regent $111,111 1 payment
Teva Pharmaceuticals USA, Inc. $54,500 1 payment
AbbVie, Inc. $16,491 9 payments

Studies the money was for Research payments · program years 2019–2025

Transform $442,252 27 payments
Og-8175A-023 $437,038 19 payments
Og-8175A-023 $169,946 30 payments
Tpx-100 $111,111 1 payment
A Randomized, Double-Blind, Multinational, Multicenter Study to Compare Efficacy, Safety, and Immunogenicity of TVB-009P and Denosumab (Prolia) in Patients With Postmenopausal Osteoporosis $54,500 1 payment
M16-283 $11,320 7 payments
M16-383 $5,171 2 payments

What the money was spent on Research payments · program years 2019–2025

Patient care $606,984 49 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.